搜索结果
ID | 拉丁名 | 药名 | 药用植物名 | 功能与主治 | 来源 | 药用部位 | 使用民族 |
---|
化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
---|
TCMBANKIN036848 | triptolide | PG 490; CT0223; Bio2_000315; AKOS015895128; KBio2_005451; BSPBio_001595; NCGC00163411-02; Triptolide; BCPP000033; Trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, [3bR-(3b.alpha.,4a.alpha.,5aS*,6.beta.,6a.beta.,7a.beta.,7b.alpha.,8aS*,8b.beta.)]-; KBio3_000629; N1733; CHEBI:94966; SCHEMBL10028421; Trisoxireno(4b,5:6,7:8a,9)phenanthro(1,2-c)furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-; AC-6084; IDI1_034065; NCGC00163411-01; NSC163062; KBio2_002883; NSC 163062; Bio2_000795; Triptolid; HY-32735; BRD-A13122391-001-01-9; SMR000466307; MLS000759410; Triptolide (9CI); C09204; Triptolide, <i>Tripterygium wilfordii; PG-490; ST51052768; KBio2_000315; Trisoxireno[4b,5:6,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, [3bR-(3b.alpha.,4a.alpha.,5aS*,6.beta.,6a.beta.,7a.beta.,7b.alpha.,8aS*,8b.beta.)]-; CS-0286; KBio3_000630; Triptolide, from Tripterygium wilfordii, >=98% (HPLC), solid; 38748-32-2; PG490; SMP1_000110; KBioGR_000315; TPL; NCI60_001223; KBioSS_000315 | C20H24O6 | 360.4 | CC(C)C12C(O1)C3C4(O3)C5(CCC6=C(C5CC7C4(C2O)O7)COC6=O)C |
靶点ID | 基因名 | 基因别名 | 描述 |
---|
TCMBANKGE000805 | SOCS3 | ATOD4; CIS3; Cish3; SOCS-3; SSI-3; SSI3 | suppressor of cytokine signaling 3 |
TCMBANKGE011415 | ASIC1 | ACCN2; ASIC; BNaC2 | acid sensing ion channel subunit 1 |
TCMBANKGE003456 | TMEM97 | MAC30 | transmembrane protein 97 |
TCMBANKGE003095 | F2RL1 | GPR11; PAR2 | F2R like trypsin receptor 1 |
TCMBANKGE000752 | Il33 | 9230117N10Rik; Il-33; Il1f11; NF-HEV | interleukin 33 |
TCMBANKGE013010 | COX2 | COII; MTCO2 | cytochrome c oxidase subunit II |
TCMBANKGE001008 | CYP3A4 | CP33; CP34; CYP3A; CYP3A3; CYPIIIA3; CYPIIIA4; HLP; NF-25; P450C3; P450PCN1 | cytochrome P450 family 3 subfamily A member 4 |
TCMBANKGE009665 | SYNPO | - | synaptopodin |
TCMBANKGE000112 | MGLL | HU-K5; HUK5; MAGL; MGL | monoglyceride lipase |
TCMBANKGE003994 | KCNK18 | K2p18.1; MGR13; TRESK; TRESK-2; TRESK2; TRIK | potassium two pore domain channel subfamily K member 18 |
TCMBANKGE000135 | CXCR4 | CD184; D2S201E; FB22; HM89; HSY3RR; LAP-3; LAP3; LCR1; LESTR; NPY3R; NPYR; NPYRL; NPYY3R; WHIM; WHIMS | C-X-C motif chemokine receptor 4 |
TCMBANKGE000274 | CCL2 | GDCF-2; HC11; HSMCR30; MCAF; MCP-1; MCP1; SCYA2; SMC-CF | C-C motif chemokine ligand 2 |
TCMBANKGE006649 | ANO1 | DOG1; ORAOV2; TAOS2; TMEM16A | anoctamin 1 |
TCMBANKGE000031 | DNMT3A | DNMT3A2; HESJAS; M.HsaIIIA; TBRS | DNA methyltransferase 3 alpha |
TCMBANKGE010263 | WAS | IMD2; SCNX; THC; THC1; WASP; WASPA | WASP actin nucleation promoting factor |
TCMBANKGE000674 | PDCD1 | CD279; PD-1; PD1; SLEB2; hPD-1; hPD-l; hSLE1 | programmed cell death 1 |
TCMBANKGE013860 | EDNRA | ET-A; ETA; ETA-R; ETAR; ETRA; MFDA; hET-AR | endothelin receptor type A |
TCMBANKGE000536 | EDNRB | ABCDS; ET-B; ET-BR; ETB; ETB1; ETBR; ETRB; HSCR; HSCR2; WS4A | endothelin receptor type B |
TCMBANKGE000331 | CALCA | CALC1; CGRP; CGRP-I; CGRP-alpha; CGRP1; CT; KC; PCT | calcitonin related polypeptide alpha |
TCMBANKGE001161 | IL2 | IL-2; TCGF; lymphokine | interleukin 2 |
TCMBANKGE003553 | SNAP25 | CMS18; RIC-4; RIC4; SEC9; SNAP; SNAP-25; SUP; bA416N4.2; dJ1068F16.2 | synaptosome associated protein 25 |
TCMBANKGE002248 | FAAH | FAAH-1; PSAB | fatty acid amide hydrolase |
TCMBANKGE003844 | MOS | MSV | MOS proto-oncogene, serine/threonine kinase |
TCMBANKGE000733 | GCH1 | DYT14; DYT5; DYT5a; GCH; GTP-CH-1; GTPCH1; HPABH4B | GTP cyclohydrolase 1 |
TCMBANKGE001073 | PTGS2 | COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 | prostaglandin-endoperoxide synthase 2 |
TCMBANKGE000966 | SIGMAR1 | ALS16; DSMA2; OPRS1; SIG-1R; SR-BP; SR-BP1; SRBP; hSigmaR1; sigma1R | sigma non-opioid intracellular receptor 1 |
TCMBANKGE008743 | OPRK1 | K-OR-1; KOP; KOR; KOR-1; KOR1; OPRK | opioid receptor kappa 1 |
TCMBANKGE000222 | EDN1 | ARCND3; ET1; HDLCQ7; PPET1; QME | endothelin 1 |
TCMBANKGE008702 | OPRM1 | LMOR; M-OR-1; MOP; MOR; MOR1; OPRM | opioid receptor mu 1 |
TCMBANKGE000471 | POMC | ACTH; CLIP; LPH; MSH; NPP; OBAIRH; POC | proopiomelanocortin |
TCMBANKGE012118 | TMPRSS2 | PRSS10 | transmembrane serine protease 2 |
TCMBANKGE011342 | NGF | Beta-NGF; HSAN5; NGFB | nerve growth factor |
TCMBANKGE000072 | CXCL12 | IRH; PBSF; SCYB12; SDF1; TLSF; TPAR1 | C-X-C motif chemokine ligand 12 |
TCMBANKGE001515 | ADM | AM; PAMP | adrenomedullin |
TCMBANKGE010277 | CYP2D6 | CPD6; CYP2D; CYP2D7AP; CYP2D7BP; CYP2D7P2; CYP2D8P2; CYP2DL1; CYPIID6; P450-DB1; P450C2D; P450DB1 | cytochrome P450 family 2 subfamily D member 6 |
TCMBANKGE000264 | ABCB1 | ABC20; CD243; CLCS; GP170; MDR1; P-GP; PGY1 | ATP binding cassette subfamily B member 1 |
TCMBANKGE001096 | TLR4 | ARMD10; CD284; TLR-4; TOLL | toll like receptor 4 |
TCMBANKGE014932 | COMT | HEL-S-98n | catechol-O-methyltransferase |
TCMBANKGE011213 | P2RY12 | ADPG-R; BDPLT8; HORK3; P2T(AC); P2Y(12)R; P2Y(AC); P2Y(ADP); P2Y(cyc); P2Y12; SP1999 | purinergic receptor P2Y12 |
TCMBANKGE000735 | VDAC1 | PORIN; VDAC-1 | voltage dependent anion channel 1 |
TCMBANKGE014995 | CYP3A5 | CP35; CYPIIIA5; P450PCN3; PCN3 | cytochrome P450 family 3 subfamily A member 5 |
TCMBANKGE001085 | MAPK8 | JNK; JNK-46; JNK1; JNK1A2; JNK21B1/2; PRKM8; SAPK1; SAPK1c | mitogen-activated protein kinase 8 |
TCMBANKGE003451 | MAP6 | MAP6-N; MTAP6; N-STOP; STOP | microtubule associated protein 6 |
TCMBANKGE000753 | CNR2 | CB-2; CB2; CX5 | cannabinoid receptor 2 |
TCMBANKGE000771 | TWIST1 | ACS3; BPES2; BPES3; CRS; CRS1; CSO; SCS; SWCOS; TWIST; bHLHa38 | twist family bHLH transcription factor 1 |
TCMBANKGE000764 | TRPV1 | VR1 | transient receptor potential cation channel subfamily V member 1 |